Case ID: 606100
Solution ID: 314

BioScale

Case Solution

In 2004, Mark Lundstrom must decide on a funding method and strategic approach for BioScale, a biotechnology company that he founded. BioScale has developed a microchip-based bioanalytical platform that can be used to detect very small concentrations of cells, viruses, proteins, or small molecules. The company has several multibillion dollar markets in its sights. Up to this point, Lundstrom has used a combination of individual and angel equity funding and government grants to meet the company's capital needs. Now he must decide whether to continue on his current "go slow to go fast strategy" or, alternatively, raise a substantial round of capital or find a strategic partner. Also explores Lundstrom's career as an entrepreneur in science-based businesses.


Request Case Study Solution

Prepared by MBAs and CFAs according to your requirements


Words
Pages
Upload

 

Already Registered? Login here!

 

Order Summary

SubjectNot Selected
LengthNot Selected
Deadline Not Selected
Estimated Submission On
Total 0